Prevalence of Schistosomiasis in Asymptomatic Dogs in Southeastern Louisiana, United States

Original Article

Austin J Vet Sci & Anim Husb. 2024; 11(1): 1138.

Prevalence of Schistosomiasis in Asymptomatic Dogs in Southeastern Louisiana, United States

Devora PA1; Bergeron C1,2; Minchew K1,3; Wolfson W1; Vatta AF4; Delcambre BA4; Liu C-C1; Moeller C1,5; Gaschen F1; Rademacher N1; Johnston AN1*

1Department of Veterinary Clinical Sciences, Louisiana State University School of Veterinary Medicine, USA

2St. Joseph’s Academy, Louisiana, USA

3Hammond Veterinary Services, Louisiana, USA

4Department of Pathobiological Sciences and Louisiana Animal Disease Diagnostic Laboratory, Louisiana State University School of Veterinary Medicine, USA

5Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, USA

*Corresponding author: Johnston AN Department of Veterinary Clinical Sciences, Louisiana State University, School of Veterinary Medicine, Skip Bertman Drive, Baton Rouge, Louisiana 70803, USA. Tel: +1 225 578 9903 Email: johnston1@lsu.edu

Received: January 19, 2024 Accepted: February 27, 2024 Published: March 05, 2024

Abstract

The schistosome parasite, Heterobilharzia americana, infects various wild and domestic mammals in the southeastern and central United States, including the domestic dog. Dogs with schistosomiasis may be asymptomatic or have systemic illness due to granulomatous inflammation within the gastrointestinal tract, lungs, liver, lymph nodes, pancreas, and spleen. Diagnosis of schistosomiasis relies on non-routine diagnostic tests such as fecal saline sedimentation and targeted PCR amplification of H. americana DNA from fecal samples. The diagnosis may be supported by certain sonographic abnormalities, which have been shown to correlate with disease. We aimed to determine the prevalence of canine schistosomiasis in free-roaming and owned dogs in southeastern Louisiana. Thirty clinically healthy, adult, free-roaming dogs and 81 clinically healthy, adult, owned dogs were screened for H. americana infection. Positivity was defined by identification of H. americana DNA extracted from fecal samples and was confirmed by visualization of ova from fecal saline sedimentation via microscopy and Sanger sequencing of amplified DNA. Only one asymptomatic client owned dog (0.9%) was positive for H. americana. The infected dog was positive on both diagnostic laboratory tests and was also found to have an abnormal small intestinal submucosal layer and mesenteric lymph node enlargement on abdominal ultrasound, sonographic changes associated with H. americana infection.

Keywords: Canine; Fluke; Heterobilharzia americana; Schistosome

Abbreviations: cGAPDH: Canine Glyceraldehyde-3-Phosphate Dehydrogenase; CI: Confidence Interval; CT: Cycle Threshold; FSS: Fecal Saline Sedimentation; LSU: Louisiana State University; PCR: Polymerase Chain Reaction; RT-PCR: Real-Time Polymerase Chain Reaction

Introduction

Heterobilharzia americana, a parasitic schistosome, poses a health risk to dogs in the central and southeastern United States [1-3]. The natural definitive hosts of H. americana are the racoon (Procyon lotor) and nutria (Myocastor coypus), but domestic dogs (Canis familiaris) may also serve as a definitive host [1,4]. Dogs are infected when they come into contact with fresh water sources harboring lymnaeid snails, the intermediate host. Free swimming cercariae, released by the snails, penetrate the skin of the definitive host and migrate through the systemic vasculature to the lungs and liver where flukes mature. Heterobilharzia are dimorphic and reproduce sexually. After ova are fertilized, eggs are released into the mesenteric vasculature, where proteolytic enzymes released by the eggs enable migration through the intestinal wall and into the feces of the host. Ova migration promotes a pro-inflammatory immune response which exacerbates tissue injury. Granulomatous inflammation is evident histologically and can result in changes visible on ultrasonography. Ultrasonographic abnormalities correlated with canine schistosomiasis include splenomegaly, thickened gastric and small intestinal submucosa, enlarged mesenteric lymph nodes, and peritoneal effusion [5]. The most commonly associated small intestinal lesions were found to be heterogenous layering and a submucosal thickness exceeding 1.5mm [6]. Small intestinal submucosal thickening and the presence of pinpoint hyperechoic foci in the liver, small intestines, and mesenteric lymph nodes were found to be specific (96.4%) for H. americana infection in dogs [6]. Clinical signs of H. americana infection include anorexia, vomiting, diarrhea, and hematochezia, but remarkably some dogs are asymptomatic [4,7,8]. A retrospective study reviewing records of H. americana infection at the Texas Veterinary Medical Diagnostic Laboratory determined that H. americana was identified incidentally in 42% of samples from biopsy and necropsy submissions [4]. Of the 20 necropsy cases where death was attributable to H. americana infection, only one case was diagnosed ante mortem [4]. Veterinarians do not routinely screen for canine schistosomiasis, even in endemic regions. Noninvasive screening methods include Fecal Saline Sedimentation (FSS) or molecular diagnostics, however these methods are not commonly employed in dogs without clinical signs. It is plausible that canine schistosomiasis is more widespread than generally recognized. The primary objective of this study was to determine the prevalence of Heterobilharzia infection in owned and free roaming dogs in southeastern Louisiana.

Materials and Methods

Study Population

Thirty clinically healthy, free-roaming dogs (group 1) and 81 clinically healthy, owned dogs (group 2) were enrolled in the study. Adult dogs with normal stool from 2 shelters in southeastern Louisiana [1,2], were enrolled in group 1. Dogs owned by the students, faculty, and staff of the Louisiana State University (LSU) Veterinary Teaching Hospital and client owned dogs from a veterinary clinic in southeastern Louisiana were enrolled in group 2 if inclusion criteria were met. Dogs were included in the study if they were greater than 1 year of age, had no current or historic gastrointestinal signs (vomiting or diarrhea), and had not received praziquantel or fenbendazole within 3 months of the study. Patient data gathered about study subjects included age, sex, breed, and weight. Owner and shelter consent was collected prior to study participation. The study protocol was approved by the Louisiana State University School of Veterinary Medicine’s Institutional Animal Care and Use Committee (IAUCAM-21-056, approval date August 25, 2021; IACUCAM 23-020, approval date February 26, 2023).

Fecal Samples

Fecal samples were gathered between June 2021 and August 2023. Samples were stored at 4°C for a maximum of 3 days. Fecal samples were then stored at -20°C until DNA extraction and molecular testing was conducted.

Fecal Saline Sedimentation (FSS)

The positive sample was confirmed by Fecal Saline Sedimentation (FSS). Approximately 3 grams of feces were mixed with 15mL of 0.13M NaCl solution in a beaker to create a slurry. The slurry was processed using a system of differential filtration followed by differential sedimentation, the FLUKEFINDER (Soda Springs, ID). The strained slurry was poured into a 50mL conical tube and allowed to sediment for 5-10 minutes. The supernatant was decanted and 2mL of sediment was transferred to a nematode counting chamber (Nematode Counting Slide, Chalex Corp, Centreville, MD). The presence of H. americana ova was determined using a light microscope (Leitz SM-LUX microscope, Stuttgart, Germany) at 4x and 10x magnification. Images were obtained using a microscope camera attached to an Olympus BX43 microscope (Olympus SC180, Tokyo, Japan) at 10x and 40x magnification focusing on the plane corresponding to the upper surface of the lower slide of the counting chamber.

DNA Extraction

DNA was extracted from 1 gram of frozen feces using a commercial kit according to the manufacturer’s protocol (QIAamp Fast DNA Stool Mini Kit, QIAGEN, Valencia, CA) with modifications to increase DNA yield: fecal supernatant from centrifuged fecal lysate was increased from 200uL to 500uL. Nucleic acid concentration was determined using a spectrophotometer (Nanodrop 1000, Thermo Fisher Scientific, Waltham, MA).

Molecular Diagnostics

Real-time PCR (RT-PCR) was performed on 111 samples using TaqMan master mix (TaqMan® Universal PCR Master Mix, Applied Biosystems, Waltham, MA) as described [9]. Canine glyceraldehyde-3-phosphate dehydrogenase (cGAPDH) cDNA was amplified according to SYBR® manufacturer’s protocols (PerfeCTa® SYBR® Green FastMix® Quantabio, Beverly, MA) as a housekeeping control to test for PCR inhibitory substances. The average melting temperature and standard deviation for samples with mean cGAPDH Cycle Threshold (Ct) was determined. Samples with mean cGAPDH Ct values greater than 35 were not included in this study [10,11]. Primer and probe RT-PCR sequences are described (Table 1). Samples were run in duplicate with positive and negative controls using either 7900HT Applied Biosystems Real-Time PCR Detection System (Applied Biosystems, Waltham, MA) or QuantStudio 12K Flex Real-Time PCR system (Applied Biosystems, Waltham, MA). To confirm positivity, a unique DNA sequence corresponding to the 18S small subunit ribosomal RNA gene was amplified (DreamTaq® Green PCR Master Mix, ThermoFisher Scientific, Waltham, MA) and sequenced (Table 2). Sanger sequencing was performed by the LSU Gene Lab and nucleotide sequences were compared to NCBI accessions of the 18S ribosomal primer sequences: AY157220.1, HQ339878.1 [12].